A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy

Published:2021-05-02 Issue:12 Volume:70 Page:3587-3602
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Lv Daojun,Wu Xiangkun,Chen Xi,Yang Shuxin,Chen Wenzhe,Wang Ming,Liu Yongda,Gu Di,Zeng Guohua^ORCID

Funder

Guangdong Basic and Applied Basic Research Foundation

Distinguished Young Talents in Higher Education Foundation of Guangdong Province

China Postdoctoral Science Foundation

Achievement cultivation and clinical transformation application cultivation projects of the First Affiliated Hospital of Guangzhou Medical University

National Natural Science Foundation of China

Collaborative Innovation Project of Guangzhou Education Bureau

Guangzhou Science, Technology and Innovation Commission

Science and Technology Planning Project of Guangdong Province

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-021-02923-6.pdf

Reference63 articles.

1. Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30. https://doi.org/10.3322/caac.21590

2. Mateo J, Fizazi K, Gillessen S, Heidenreich A, Perez-Lopez R, Oyen WJG, Shore N, Smith M, Sweeney C, Tombal B, Tomlins SA, de Bono JS (2019) Managing nonmetastatic castration-resistant prostate cancer. Eur Urol 75(2):285–293. https://doi.org/10.1016/j.eururo.2018.07.035

3. Lu X, Horner JW, Paul E, Shang X, Troncoso P, Deng P, Jiang S, Chang Q, Spring DJ, Sharma P, Zebala JA, Maeda DY, Wang YA, DePinho RA (2017) Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature 545(7652):116. https://doi.org/10.1038/nature21676

4. Aragon-Ching JB, Siegel R, Frazier H II, Andrawis R, Hendricks F, Phillips M, Jarrett T, Guebre-Xabiher H, Patierno S, Simmens SJ (2015) Circulating tumor cells in biochemical recurrence of prostate cancer. Clin Genitourin Cancer 13(5):e341-345. https://doi.org/10.1016/j.clgc.2015.04.003

5. Liesenfeld LKM, Gschwend JE, Herkommer K (2016) Prognostic factors for biochemical recurrence more than 10 years after radical prostatectomy. J Urol 197(1):143–148. https://doi.org/10.1016/j.juro.2016.07.004

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of anoikis-related gene signatures and construction of the prognosis model in prostate cancer;Frontiers in Pharmacology;2024-06-18

2. Investigating the Role of SNAI1 and ZEB1 Expression in Prostate Cancer Progression and Immune Modulation of the Tumor Microenvironment;Cancers;2024-04-12

3. Identification of a 9-gene signature to enhance biochemical recurrence prediction in primary prostate cancer: A benchmarking study using ten machine learning methods and twelve patient cohorts;Cancer Letters;2024-04

4. Role of interferon regulatory factor 5 (IRF5) in tumor progression: Prognostic and therapeutic potential;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01

5. A tumor-associated macrophages related model for predicting biochemical recurrence and tumor immune environment in prostate cancer;Genomics;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3